Diagnostic challenge of GAD65-associated autoimmune encephalitis mimicking post-traumatic complications in an older adult: a case report
Authors:
Open Access
- 26 August 2026
- journal article
- case report
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 13, 1929756
Abstract
Introduction: Glutamic acid decarboxylase 65 (GAD65) antibody-associated autoimmune encephalitis is an uncommon immune-mediated neurological disorder with heterogeneous neuropsychiatric manifestations. Diagnosis is particularly challenging in older adults when symptoms of recent traumatic brain injury (TBI) overlap with structural or metabolic conditions. Case presentation: We report a 79-year-old man who developed recurrent headache, progressive confusion, abnormal behavior, poor oral intake, intermittent myoclonic jerks, and low-grade fever after TBI complicated by chronic subdural hematoma. Initial laboratory testing revealed hyponatremia, and the working diagnosis was post-traumatic brain syndrome with syndrome of inappropriate antidiuretic hormone secretion (SIADH). Although serum sodium was corrected and nocturnal agitation partially improved, persistent daytime confusion, cognitive impairment, behavioral abnormalities, and low-grade fever prompted further investigation. Cerebrospinal fluid (CSF) analysis showed mild inflammatory changes with pleocytosis and elevated protein. CSF metagenomic next-generation sequencing (mNGS) and paraneoplastic antibody testing were negative, whereas the autoimmune encephalitis panel was positive for GAD65 antibody at a titer of 1:32. Whole-body positron emission tomography-computed tomography (PET-CT) did not reveal malignancy. The diagnosis was therefore revised to GAD65 antibody-associated autoimmune encephalitis. Because high-dose corticosteroids were considered unsuitable owing to his history of gastric ulcer and previous gastrointestinal bleeding, he was treated with intravenous immunoglobulin (IVIG) at a total dose of 2 g/kg divided over 3 consecutive days followed by oral azathioprine 50 mg daily. His fever resolved within 1 week, and his mental status and responsiveness gradually improved. At 6-month follow-up, he had achieved near-baseline mental status, was able to walk with a cane, and was almost fully independent in daily activities, without relapse or serious treatment-related adverse events. Discussion: This case highlights the diagnostic difficulty of recognizing autoimmune encephalitis after TBI. The clinical overlap between post- traumatic syndrome and immune-mediated brain injury often delays diagnosis, emphasizing the value of targeted CSF autoantibody testing in atypical cases. Conclusion: Traumatic brain injury may obscure the onset of GAD65-associated autoimmune encephalitis. Early recognition and a corticosteroid-sparing immunotherapy strategy (IVIG and azathioprine) can yield favorable outcomes in elderly patients with medical comorbidities.Keywords
This publication has 27 references indexed in Scilit:
- Immunotherapy for autoimmune encephalitisCell Death Discovery, 2025
- Autoimmune EncephalitisMedical Clinics of North America, 2025
- The limbic and extra-limbic encephalitis associated with glutamic acid decarboxylase (GAD)-65 antibodies: an observational studyNeurological Sciences, 2024
- Seven-year performance of a clinical metagenomic next-generation sequencing test for diagnosis of central nervous system infectionsNature Medicine, 2024
- Immune Response in Traumatic Brain InjuryCurrent Neurology and Neuroscience Reports, 2024
- MRI findings in autoimmune encephalitisRevue Neurologique, 2024
- Autoimmune encephalitis: recent clinical and biological advancesJournal of Neurology, 2023
- Autoimmune Encephalitis Misdiagnosis in AdultsJAMA Neurology, 2022
- Psychiatric manifestations of autoimmune encephalitisAutoimmunity Reviews, 2022
- Immune-mediated epilepsy with GAD65 antibodiesJournal of Neuroimmunology, 2020